Aclaris Therapeutics, Inc.ACRSNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-20.20M
↑ 65% above average
Average (9y)
$-57.14M
Historical baseline
Range
High:$-20.20M
Low:$-102.17M
CAGR
-0.4%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-20.20M | +74.6% |
| 2023 | $-79.63M | -16.8% |
| 2022 | $-68.17M | -30.0% |
| 2021 | $-52.44M | -34.2% |
| 2020 | $-39.09M | +60.1% |
| 2019 | $-98.06M | +4.0% |
| 2018 | $-102.17M | -82.8% |
| 2017 | $-55.90M | -60.5% |
| 2016 | $-34.84M | -66.9% |
| 2015 | $-20.88M | - |